KYMRIAH
LIVE

Serial Number

79219217

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

KYMRIAH Trademark

Serial Number: 79219217 • Registration: 5404058

KYMRIAH is a trademark filed by NOVARTIS AG on July 28, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,173 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 28, 2017

Registration Date

February 20, 2018

Published for Opposition

December 5, 2017

Goods & Services

[ Pharmaceutical and biological preparations for medical diagnostic use; ] pharmaceutical and biological preparations for medical use, namely, for [ the prevention and treatment of diseases and disorders of the nervous system, the immune system * and * , the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, ] oncology [ , hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations ]

Collection and preservation of biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatment

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 31, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 27, 2025 INPS
INVALIDATION PROCESSED
Sep 27, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 25, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sep 27, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Sep 27, 2024 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 27, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Sep 25, 2024 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2024 APRE
INTERNATIONAL REGISTRATION RENEWED
Mar 7, 2024 RNWL
TEAS SECTION 71 & 15 RECEIVED
Jan 19, 2024 ES75
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 7, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 2, 2021 INPR
AMENDMENT UNDER SECTION 7 - PROCESSED
Nov 2, 2020 A7OK
COUNTERCLAIM OPP. NO. 999999
Jan 2, 2020 CCON
NOTIFICATION PROCESSED BY IB
Apr 19, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 30, 2018 FICS
FINAL DISPOSITION PROCESSED
Mar 30, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Mar 22, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2018 R.PR
PUBLISHED FOR OPPOSITION
Dec 5, 2017 PUBO
NOTICE OF PUBLICATION
Nov 15, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2017 CNSA
APPLICATION FILING RECEIPT MAILED
Oct 31, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 24, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 19, 2017 SDRC